O’Connell, Grant C.
Treadway, Madison B.
Tennant, Connie S.
Lucke-Wold, Noelle
Chantler, Paul D.
Barr, Taura L.
Funding for this research was provided by:
National Institutes of Health (P20 GM109098)
Robert Wood Johnson Foundation (70319)
Article History
Received: 11 November 2017
Revised: 12 February 2018
Accepted: 9 March 2018
First Online: 17 March 2018
Compliance with Ethical Standards
: Procedures were approved by the institutional review boards of West Virginia University and Ruby Memorial Hospital (IRB protocol 1410450461R001), and written informed consent was obtained from all subjects or their authorized representatives prior to study procedures.
: GCO and TLB have a patent pending re: genomic patterns of expression for stroke diagnosis. TLB serves as chief scientific officer for Valtari Bio Incorporated. Work by GCO is part of a pending licensing agreement with Valtari Bio Incorporated. GCO has received consulting fees from Valtari Bio Incorporated. The remaining authors report no potential conflicts of interest.